CBSM phone app eases anxiety, depression in cancer patientsJune 23, 2023Breast CancerGenitourinary CancerLung CancerMelanomaAMLMultiple MyelomaMyelodysplastic Syndrome
Drugmakers are abandoning cheap generics, and now U.S. cancer patients can’t get medsJune 22, 2023Breast CancerGenitourinary CancerLung CancerMelanomaAMLMultiple MyelomaMyelodysplastic Syndrome
Number of cancer survivors with functional limitations doubled in 20 yearsMay 11, 2023Lung CancerOncologyDiversity in MedicineGeriatricsBreast CancerMixed TopicsGenitourinary Cancer
AFib risk with cancer drugs underestimatedApril 12, 2023Breast CancerLung CancerImmuno-oncologyAMLMultiple Myeloma
Multiple myeloma diagnosed more via emergency care during COVIDDecember 19, 2022Multiple MyelomaOncologyCOVID-19 UpdatesHematologic Malignancies
Blenrep for multiple myeloma withdrawn from U.S. marketNovember 22, 2022Multiple MyelomaBusiness of MedicineHematologic Malignancies
CAR T-cell therapy neurotoxicity linked to NfL elevationsOctober 3, 2022Multiple MyelomaMixed TopicsHematologic Malignancies
Agent Orange Exposure, Transformation From MGUS to Multiple Myeloma, and Outcomes in VeteransAugust 9, 2022Multiple MyelomaHematologic Malignancies
Fewer transplants for MM with quadruplet therapy?August 1, 2022Multiple MyelomaHematologic MalignanciesCancerOncology
